Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Lantus is a prescription long-acting insulin containing insulin glargine. It is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Lantus contains 100 units per mL and is supplied in a 10 mL vial and 3 mL SoloStar prefilled pens.
read more about lantus ...Insulin glargine lowers blood glucose by increasing glucose uptake into skeletal muscle and fat and by reducing glucose production by the liver. After subcutaneous injection, it forms microprecipitates that release small amounts of insulin glargine over an extended period.
Lantus is used in adults and pediatric patients with diabetes mellitus who require basal insulin. In type 1 diabetes, Lantus is used with short-acting insulin. It is not recommended for treatment of diabetic ketoacidosis.
Lantus is injected subcutaneously once daily at the same time each day. In insulin-naive adults with type 2 diabetes, the recommended starting dose is 0.2 units per kg or up to 10 units once daily. In type 1 diabetes, the starting dose is about one-third of the total daily insulin requirement, with the remainder supplied by short-acting mealtime insulin.
Hypoglycemia is the most common serious risk of insulin therapy. Other concerns include severe hypersensitivity, hypokalemia, medication errors, lipodystrophy, localized cutaneous amyloidosis, and fluid retention or heart failure when used with peroxisome proliferator-activated receptor gamma agonists. Lantus is not mixed with other insulins or given intravenously.
Lantus improves glycemic control in adults and pediatric patients with diabetes mellitus.
Lantus is injected subcutaneously once daily at the same time each day.
The recommended starting dose is 0.2 units per kg or up to 10 units once daily.
No. Current labeling directs against diluting or mixing Lantus with another insulin or liquid.
DailyMed - LANTUS (insulin glargine) injection, solution. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5e07a0c-7e14-4756-9152-9fea485d654a. Date Accessed October 8, 2026.
Insulin Glargine (rDNA origin) Injection. MedlinePlus. https://www.medlineplus.gov/druginfo/meds/a600027.html. Date Accessed October 8, 2026.
Insulin Glargine. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Insulin-glargine. Date Accessed October 8, 2026.
Insulin. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK560688/. Date Accessed October 8, 2026.
LANTUS (insulin glargine) Prescribing Information. Sanofi. https://products.sanofi.us/lantus/lantus.pdf. Date Accessed October 8, 2026.